$Actinium (ATNM.US)$
Revolutionary Triple-Drug Combination Trial Targets Newly Diagnosed AML Patients

$Actinium (ATNM.US)$ SECuRE Trial Update: 92% of Pre-chemo Participants Experience Greater Than 35% Drop in PSA Levels Across All Cohorts. Cohort Expansion Phase Commences.
PR Newswire
5 mins ago
HIGHLIGHTS
Safety Review Committee (SRC) meeting confirms end of the Dose Escalation Phase and commencement of the Cohort Expansion Phase (Phase II stage) of the SECuRE study.
Based on the efficacy and safety assessment of all cohorts and the focus on earlier stages of treatment, the SRC confirmed...

$Actinium (ATNM.US)$ NorthStar Medical Radioisotopes and YAP Therapeutics Enter Into Collaboration Agreement for the Development and Production of Radiopharmaceutical Products
Businesswire· 13 mins ago
NorthStar to support the development of YAP Therapeutics' innovative radiolabeled productsThis collaboration merges the expertise and resources from both companies, including NorthStar's state-of-the-art facilitiesThe agreement guarantees that YAP Therapeutics will receive clinical trial-read...

$Actinium (ATNM.US)$ SK Biopharmaceuticals Seals 1st Actinium-225-Based Collaborative Research Agreement With Korea Institute of Radiological and Medical Sciences as Steps Toward Becoming Global Radiopharmaceutical Therapy Player
PR Newswire· 10 mins ago
SK Biopharmaceuticals, Korea Institute of Radiological and Medical Sciences collaborate on discovering and developing radiopharmaceutical drug candidates using an alpha-particleemittingradioisotope, actinium-225, for potential cancer treatm...

$Actinium (ATNM.US)$ Not sure why this didn't pop up on the Moomoo news fees but it's back to another Phase 3 for their AML drug.
Actinium Announces Publication Of Phase 3 SIERRA Results Of Iomab-B - Quick Facts
Good lesson on the higher risks of biologics though. BLA (biologics license application) a relatively new classification (maybe 5 or so years?)  meant to divert biologics from the NDA process that small molecule drugs go through.
In practical terms,...

$Actinium (ATNM.US)$ Reuters· just
Actinium Pharmaceuticals Inc - Iomab-B Well Tolerated in Older Relapsed/Refractory Aml Patients

$Actinium (ATNM.US)$       Abdera Therapeutics Announces FDA Orphan Drug Designation for ABD-147 for the Treatment of Neuroendocrine Carcinoma
September 05, 2024 08:00 AM Eastern Daylight Time!!! From this morning!  BUT THIS ONE BELOW JUST WAS RELEASED VIA SEEKING ALPHA! NOT SURE IF THEY ARE MISPRINT OF DRUG? OR ANOTHER APPROVAL?
 Perspective gets FDA fast track status for radiopharmaceutical VMT101

$Actinium (ATNM.US)$ come on, let's get back to where it's supposed to be!

$Actinium (ATNM.US)$ boom boy 🐎🐎🐎

$Actinium (ATNM.US)$ expected  2.75 but 2.50 is not bad, eow we might see 4.50 +